anti-corona vaccine
The director of the American Institute of Infectious Diseases, Anthony Fauci
Yesterday, Monday, the director of the American Institute of Infectious Diseases, Anthony Fauci, expressed his happiness with the American company “Moderna” announcing that its experimental anti-corona vaccine is about 95% effective.

Fauchi, a member of the Presidential Coronavirus Cell, told “Agence France Presse”: “The idea of ​​having a vaccine that is effective at 94.5% is amazingly amazing,” stressing that this result is “really amazing”, and he does not think that anyone expected it to be “good to This limit. ”

He mentioned that “many people had reservations about this technology, which had not yet been tested and proven effective,” noting that “some have criticized them for that.”

The alliance of the American “Pfizer” company “and” German company “Bayontek” announced last week that its experimental anti-Corona vaccine, which is based on the same technology, has proven 90% effective in preventing infection with the virus.

Fauci told AFP that these two results confirm “the safety of this technology,” because “the data speak for themselves by themselves.”

He continued: “I think that when you have two vaccines like these two vaccines that have proven effective by more than 90%, the technology will not have to provide more evidence.”

The infectious disease expert also warned that “there is still a long way to go,” warning of “the logistical difficulties encountered in the process of transporting vaccine doses,” expressing his deep concern about “the anti-vaccination culture that prevails among a large segment of Americans.”

He added: “There is a widespread anti-vaccination feeling in this country, (meaning the United States), and we must be able to overcome it and persuade people to get vaccinated, as no highly effective vaccine is of no use if no one is vaccinated with it.”

Yesterday, the American company “Moderna” announced that the effectiveness of its vaccine against the Coronavirus has proven, according to provisional data for the last stage of clinical tests, its effectiveness of 94.5%.

It should be noted that the “Moderna” vaccine is based on modern technology, based on the introduction of genetic instructions into human cells, to stimulate them to produce a protein identical to the protein of the Coronavirus, and to cause an immune response against this protein, according to “France Press”.

Source: AFP

LEAVE A REPLY

Please enter your comment!
Please enter your name here